Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof
申请人:Eickmeier Christian
公开号:US20090325940A1
公开(公告)日:2009-12-31
The present invention relates to substituted 1,2-ethylenediamines of general formula (I)
wherein the groups R
1
to R
15
, A, B, L, i as well as X
1
-X
4
are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.
US7713961B2
申请人:——
公开号:US7713961B2
公开(公告)日:2010-05-11
New Compounds. Some Aryl and Aralkyl Ureas
作者:Johannes Buck、Richard Baltzly、Alan Ardis
DOI:10.1021/ja01230a047
日期:1944.2
Synthetic Analogs of Oxytocic Drugs. I. Phenethyl β-Alanine Derivatives
作者:Richard. Baltzly、Vladimir. Dvorkovitz、Arthur P. Phillips
DOI:10.1021/ja01172a009
日期:1949.4
known to shift from the 5-10 to the 9-10 position in transformations between the lysergic and isolysergicacid families of the ergotalkaloids. The contributions of the wrious portions of the molecule to its physiological activity are not known, although some information is available. The other ergotalkaloids, in which the group R is replaced by complex cyclic structures, manifest very different physiological